Nice find. When I look at the possibilities ahead, I am getting more and more convinced we should go it alone for Phase 3 and subsequently license the drug. At close to $1B MC, we can afford to raise for a $200M trial. It appears we have some strong support from a few funds who continue to buy up at these levels and would happily open up the purse strings for a potential 5-Disallowed from here.
price target, page-25
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
0.040(4.57%) |
Mkt cap ! $1.126B | |||
| Open | High | Low | Value | Volume |
| 91.0¢ | 92.0¢ | 88.5¢ | $3.082M | 3.401M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27049 | 90.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 10000 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |